Tri Locum Partners as of June 30, 2024
Portfolio Holdings for Tri Locum Partners
Tri Locum Partners holds 25 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 10.5 | $41M | 2.6M | 16.25 | |
| Argenx Se Sponsored Adr (ARGX) | 8.1 | $32M | 75k | 430.04 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 7.9 | $31M | 228k | 136.38 | |
| Amgen (AMGN) | 6.5 | $26M | 82k | 312.45 | |
| Natera (NTRA) | 6.3 | $25M | 231k | 108.29 | |
| Axsome Therapeutics (AXSM) | 6.2 | $25M | 307k | 80.50 | |
| Insmed Com Par $.01 (INSM) | 5.4 | $21M | 317k | 67.00 | |
| Merus N V (MRUS) | 5.0 | $20M | 336k | 59.17 | |
| Regeneron Pharmaceuticals (REGN) | 4.7 | $18M | 18k | 1051.03 | |
| Madrigal Pharmaceuticals (MDGL) | 4.6 | $18M | 65k | 280.16 | |
| Inspire Med Sys (INSP) | 4.5 | $18M | 133k | 133.83 | |
| Avadel Pharmaceuticals Sponsored Adr | 4.2 | $17M | 1.2M | 14.06 | |
| Pfizer (PFE) | 4.2 | $17M | 597k | 27.98 | |
| United Therapeutics Corporation (UTHR) | 4.0 | $16M | 50k | 318.55 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 4.0 | $16M | 357k | 44.29 | |
| Alnylam Pharmaceuticals (ALNY) | 2.8 | $11M | 45k | 243.00 | |
| Stevanato Group S P A Ord Shs (STVN) | 2.6 | $10M | 565k | 18.34 | |
| Novo-nordisk A S Adr (NVO) | 2.3 | $9.1M | 64k | 142.74 | |
| Vaxcyte (PCVX) | 2.2 | $8.6M | 113k | 75.51 | |
| Xenon Pharmaceuticals (XENE) | 1.0 | $4.0M | 102k | 38.99 | |
| Ocular Therapeutix (OCUL) | 0.9 | $3.5M | 515k | 6.84 | |
| Praxis Precision Medicines I Com New (PRAX) | 0.8 | $3.1M | 75k | 41.36 | |
| Mind Medicine Mindmed Com New (MNMD) | 0.7 | $2.8M | 382k | 7.21 | |
| Korro Bio (KRRO) | 0.6 | $2.4M | 71k | 33.87 | |
| Femasys (FEMY) | 0.0 | $35k | 31k | 1.14 |
